Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: Bayer

Controversial Sterilization Device Should be Taken Off the Market



The U.S. Food and Drug Administration (FDA) has announced that it has approved a boxed warning for Bayer’s controversial Essure® sterilization device. A boxed warning is the strongest warning the FDA can require for drugs and devices and is intended to alert the user to potentially serious, even deadly, side effects that can result from using them. The Essure boxed warning will alert patients and health professionals to adverse events associated with the device including …

Read more.




Women Deliver: Gates Global Push for Abortion Continues



The Malaysia conference highlights how to market a drug for one thing and use it for another, how euphemisms work and how it is up to government to create demand for contraception. It's being billed as "the largest global event of the decade to focus on the health and empowerment of girls and women." But it is also very obviously a conference designed to reduce populations of developing nations by promoting a Western-style sexual revolution …

Read more.




The Mirena IUD is Becoming More Popular – and the Lawsuits are Piling Up



You know a contraceptive drug or device is in trouble when the lawsuits begin to multiply. A growing number of American women are turning to intrauterine devices (IUDs), reports Lawrence Finer of the Guttmacher Institute. Of all American women using birth control, some 7.5 percent had IUDs implanted by 2009. These numbers were double what they had been a few short years before. As befits an employee of a population control organization, Finer is pleased …

Read more.




Norplant is Back–Under a Different Name



Ten years ago PRI drove a stake through the heart of Norplant, an abortifacient contraceptive that had harmed thousands of women in the U.S. and many more around the world. But it refused to die.

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.